Interesting ImagesIncidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate CancerGoineau, Aurore MD*; Colombié, Mathilde MD*; Rousseau, Caroline MD, PhD*†; Sadot-Lebouvier, Sophie MD*; Supiot, Stéphane MD, PhD* Author Information From the *Institut de Cancérologie de l’Ouest René Gauducheau, Saint-Herblain; and †Centre de Recherche en Cancérologie de Nantes Angers, Inserm U892, Centre National de la Recherche Scientifique UMR 6299, University of Nantes, Nantes, France. Received for publication September 4, 2014; revision accepted March 10, 2015. Conflicts of interest and sources of funding: none declared. Reprints: Aurore Goineau, Institut de Cancérologie de l’Ouest René Gauducheau, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France. E-mail: [email protected]. Clinical Nuclear Medicine 40(8):p 670-671, August 2015. | DOI: 10.1097/RLU.0000000000000817 Buy Metrics Abstract Combined PET/CT scanning with 18F-FDG is in current use in Hodgkin lymphoma. New tracers have been developed, such as 18F-choline in prostate cancer. Its use is under investigation in other solid tumors (eg, brain, liver, lung). We report a case of Hodgkin lymphoma incidentally detected on 18F-choline PET/CT in a prostate cancer patient and show a comparison with 18F-FDG PET/CT. 18F-choline PET/CT detected more lymph node lesions than the 18F-FDG PET/CT for this patient. Comparative studies of the 2 tracers might help fine-tune treatments and, in particular, delineate target zones in radiation therapy. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.